Daniel Sing-kwong Tsze
NIH Rank #1367
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10750154Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Emergency Medicine
NIH Funding · FY2024
Linked Award Amount
$4.4M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#1,367
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Daniel Sing-kwong Tsze as a PI. Multi-PI records show the full award amount for context.
- 1U01HD116253-01U01Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.$3.4Maward amount
- 5R01NS110826-05R01Headache Assessment of Children for Emergent Intracranial Abnormalities$1Maward amount
Award organization
Organizations that administered FY2024 awards listing Daniel Sing-kwong Tsze as a PI.
FY2024 award administered by Columbia University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardColumbia University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1367
- 2024Entered Top 25% NationallyRanked #1367
- 2024Entered Top 10% NationallyRanked #1367
- 2024R01 Grant Holder
- 2025$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Daniel Sing-kwong Tsze.